Lawmakers Would Give Even More Incentives to Antibiotics

Clinical Trials Advisor
Drugmakers could be required to submit less data for antibiotics and antifungals that affect limited patient populations if a new House bill aimed at building on the success of the Generating Antibiotics Now Act is passed into law.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00